HIF1A and Familial prostate cancer: Another study indicates that evodiamine can inhibit prostate cancer growth by reducing lactylation of hypoxia‐inducible factor 1 alpha (HIF1α) in prostate cancer cells, a finding corroborated by animal experiments.